Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma

New England Journal of Medicine

Volumn 369, Issue 6, 2013, Pages 584-586

  Baudry, Camille ^a   Paepegaey, Anne Cécile ^b   Groussin, Lionel ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hôpital Cochin ^*  (France)

^c French Tumeurs de la Thyroide Refractaires Network   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CORTICOTROPIN; DESMOPRESSIN; HYDROCORTISONE; KETOCONAZOLE; METYRAPONE; MITOTANE; SOMATOSTATIN DERIVATIVE; VANDETANIB;

ADULT; ANTISECRETORY ACTIVITY; CALCITONIN BLOOD LEVEL; CASE REPORT; CERVICAL LYMPH NODE; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG EFFECT; DRUG WITHDRAWAL; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MEDULLARY CARCINOMA; MOLECULARLY TARGETED THERAPY; MUSCLE WEAKNESS; NEUTROPENIA; PRIORITY JOURNAL; THYROID CARCINOMA; WALKING DIFFICULTY;

EID: 84881228422     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1301428     Document Type: Letter

References (5)

1. Wells SA Jr, Robinson BG, Gagel RF, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol 2012;30:134-41.
2. Tsagarakis S, Tsigos C, Vasiliou V, et al. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 2002;87:1646-53. (Pubitemid 34615253)
3. Donadille B, Groussin L, Waintrop C, et al. Management of Cushing's syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para′-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single center. J Clin Endocrinol Metab 2010;95:537-44.
4. Kamenicky P, Droumaguet C, Salenave S, et al. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 2011;96:2796-804.
5. Akeno-Stuart N, Croyle M, Knauf JA, et al. The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells. Cancer Res 2007;67:6956-64. (Pubitemid 47105543)